ITHACA — Rheonix, Inc., an Ithaca–based microfluidics company, today announced the addition of Frank Gill as vice president of manufacturing.
Gill will be responsible for formulating and executing the company’s operations strategy as it scales from prototype volumes to fully-automated production of life science and in-vitro diagnostics products, the company said in a news release.
Gill will oversee manufacturing of Rheonix-instrument platforms, reagent kits, and the Rheonix CARD system, an automated-microfluidic platform capable of analyzing raw samples in a variety of applications, the company said.
(Sponsored)
Asset Acquisition Strategies: Choosing Between Financing, Leasing or Buying
When acquiring business equipment or machinery, how you choose to pay can significantly impact your cash flow, tax strategy and long-term financial position. The three primary optionsare financing, leasing and
Recent Court Decision Supports Requiring Employees to Be In the Workplace
A recent Federal Court decision confirmed that the Family Medical Leave Act (FMLA) does not require employers to allow employees to work remotely. In Kemp v. Regeneron Pharmaceuticals, Inc.,
Most recently, Gill served as director of reagent-manufacturing operations at 454 Life Sciences, a division of the Switzerland–based Roche Group.
Contact Reinhardt at ereinhardt@cnybj.com
